23 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/23/3047498/0/en/UNITY-Biotechnology-to-Host-Virtual-Investor-Event-to-Discuss-24-and-36-Week-Data-from-the-Phase-2b-ASPIRE-Study-of-UBX1325-in-Patients-with-Diabetic-Macular-Edema-DME-on-March-24-.html
23 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/23/2867620/0/en/UNITY-Biotechnology-Announces-Extension-of-Phase-2b-ASPIRE-Clinical-Study-Evaluating-UBX1325-in-DME.html